• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5型磷酸二酯酶抑制剂:沙特阿拉伯的不合理使用情况

Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia.

作者信息

Alshahrani Saad, Ahmed Abul-Fotouh, Gabr Ahmed H, Al Ansari Ahmed, El-Feky Mohamed, Elbadry Mohamed S

机构信息

Department of Urology, College of Medicine, Prince Sattam Bin Abdulaziz University, Saudi Arabia.

Department of Urology, College of Medicine, Prince Sattam Bin Abdulaziz University, Saudi Arabia; Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

出版信息

Arab J Urol. 2016 May 5;14(2):94-100. doi: 10.1016/j.aju.2016.03.003. eCollection 2016 Jun.

DOI:10.1016/j.aju.2016.03.003
PMID:27489735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4963165/
Abstract

OBJECTIVE

To identify the criteria of phosphodiesterase type 5 inhibitor (PDE5i) users and to analyse the knowledge, attitude, and practices of PDE5i use amongst Saudi men.

SUBJECTS AND METHODS

A web-based, cross-sectional survey was conducted in Saudi Arabia between January and April 2015. Sexually active adult men were interviewed using a website questionnaire designed by the authors. Descriptive statistics were used to analyse the data.

RESULTS

In all, 1008 men participated in the survey with 378 (37.5%) reporting use of PDE5i. Of those using PDE5i, 144 (38.1%) reported erectile dysfunction and 234 (61.9%) reported normal erection (recreational users). We found several demographic features, including high education level, health field occupation, high income, smoking, and increased frequency of sexual intercourse amongst the PDE5i users. Most of the PDE5i users (92.3%) had knowledge about PDE5i and 84.1% of them bought it without medical prescription. The most commonly used PDE5i was tadalafil (46.1%) and most of the users (79.9%) reported improvement in their sexual activity after PDE5i usage. Amongst the recreational users, the main reasons for PDE5i usage were curiosity (38.5%) and improving self-confidence (25.6%). Of them, 69.2% reported benefits from PDE5i usage, mainly in the form of enhancement of erection (36.7%) and increasing erection duration (31.2%).

CONCLUSION

PDE5i use appears to be frequent in Saudi Arabia. Most of the users had knowledge about PDE5i and claimed to get benefits from it, even if used as a recreational drug.

摘要

目的

确定5型磷酸二酯酶抑制剂(PDE5i)使用者的标准,并分析沙特男性使用PDE5i的知识、态度和行为。

对象与方法

2015年1月至4月在沙特阿拉伯进行了一项基于网络的横断面调查。对性活跃的成年男性使用作者设计的网站问卷进行访谈。采用描述性统计分析数据。

结果

共有1008名男性参与调查,其中378名(37.5%)报告使用过PDE5i。在使用PDE5i的人群中,144名(38.1%)报告有勃起功能障碍,234名(61.9%)报告勃起功能正常(娱乐性使用者)。我们发现了一些人口统计学特征,包括高学历、卫生领域职业、高收入、吸烟以及PDE5i使用者中性交频率增加。大多数PDE5i使用者(92.3%)了解PDE5i,其中84.1%在没有医生处方的情况下购买。最常用的PDE5i是他达拉非(46.1%),大多数使用者(79.9%)报告使用PDE5i后性活动有所改善。在娱乐性使用者中,使用PDE5i的主要原因是好奇(38.5%)和增强自信心(25.6%)。其中,69.2%报告使用PDE5i有好处,主要表现为勃起增强(36.7%)和勃起持续时间延长(31.2%)。

结论

在沙特阿拉伯,PDE5i的使用似乎很频繁。大多数使用者了解PDE5i,并声称从中受益,即使是作为娱乐性药物使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df5/4963165/9bc19c2ac363/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df5/4963165/9bc19c2ac363/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df5/4963165/9bc19c2ac363/gr1.jpg

相似文献

1
Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia.5型磷酸二酯酶抑制剂:沙特阿拉伯的不合理使用情况
Arab J Urol. 2016 May 5;14(2):94-100. doi: 10.1016/j.aju.2016.03.003. eCollection 2016 Jun.
2
Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men.性增强药物使用者的人口统计学和性特征:对性活跃男性基于网络的横断面样本的研究。
Arab J Urol. 2017 Nov 6;15(4):366-371. doi: 10.1016/j.aju.2017.09.003. eCollection 2017 Dec.
3
Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.口服联合治疗方案治疗磷酸二酯酶 5 型抑制剂单药治疗失败的勃起功能障碍的系统评价
Sex Med Rev. 2019 Jul;7(3):430-441. doi: 10.1016/j.sxmr.2018.11.007. Epub 2019 Jan 30.
4
A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.一项为期 6 个月的前瞻性观察性研究,旨在评估 PDE5 抑制剂治疗中东和北非地区勃起功能障碍男性患者的持续性和依从性。
Curr Med Res Opin. 2013 Jun;29(6):707-17. doi: 10.1185/03007995.2013.791263. Epub 2013 Apr 17.
5
Study of the prevalence and patterns of phosphodiesterase type 5 inhibitor use among sexually active Egyptian males: A National Cross-sectional Survey.埃及活跃男性人群中磷酸二酯酶 5 抑制剂使用的流行率和模式研究:一项全国性横断面调查。
Andrologia. 2019 Oct;51(9):e13364. doi: 10.1111/and.13364. Epub 2019 Jul 15.
6
PDE5is-naïve versus non-naïve patients at first investigation for erectile dysfunction-findings from a long-term, real-life cross-sectional study.初次检查勃起功能障碍时未使用过磷酸二酯酶5抑制剂(PDE5is)与使用过的患者——一项长期、真实生活横断面研究的结果
Andrology. 2025 Feb;13(2):323-330. doi: 10.1111/andr.13641. Epub 2024 Apr 8.
7
Recreational use of phosphodiesterase type 5 inhibitors by healthy young men.健康年轻男性 recreational 使用 5 型磷酸二酯酶抑制剂。
J Sex Med. 2010 Nov;7(11):3736-42. doi: 10.1111/j.1743-6109.2010.01965.x. Epub 2010 Aug 16.
8
Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, function and satisfaction in a population sample of older men.勃起功能障碍与5型磷酸二酯酶抑制剂的使用:老年男性人群样本中性活动、功能及满意度的关联
Int J Impot Res. 2015 Jul;27(4):146-51. doi: 10.1038/ijir.2015.4. Epub 2015 Mar 26.
9
Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction.真空勃起装置与 PDE5 抑制剂联合治疗勃起功能障碍患者中 PDE5 抑制剂无反应者的挽救治疗。
J Sex Med. 2009 Sep;6(9):2561-7. doi: 10.1111/j.1743-6109.2009.01364.x. Epub 2009 Jul 16.
10
Long-term effectiveness and predictors of success of low-intensity shockwave therapy in phosphodiesterase type 5 inhibitors non-responders.5型磷酸二酯酶抑制剂无反应者中低强度冲击波治疗的长期疗效及成功预测因素
Arab J Urol. 2019 Nov 11;18(1):54-58. doi: 10.1080/2090598X.2019.1688072. eCollection 2020.

引用本文的文献

1
Recreational use of oral erectile dysfunction medications among male physicians - A cross-sectional study.男性医生中口服勃起功能障碍药物的娱乐性使用——一项横断面研究。
Urol Ann. 2023 Apr-Jun;15(2):148-157. doi: 10.4103/ua.ua_33_22. Epub 2023 Jan 16.
2
Top 10 most used drugs in the Kingdom of Saudi Arabia 2010-2015.2010 - 2015年沙特阿拉伯王国使用最频繁的十大药物。
Saudi Pharm J. 2018 Feb;26(2):211-216. doi: 10.1016/j.jsps.2017.12.009. Epub 2017 Dec 15.
3
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil.

本文引用的文献

1
Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men: the mediating role of confidence in erectile ability.年轻人健康男性中,使用勃起功能障碍药物进行娱乐活动及其对勃起功能的不良影响:勃起能力信心的中介作用。
J Sex Med. 2012 Jul;9(7):1852-9. doi: 10.1111/j.1743-6109.2012.02755.x. Epub 2012 May 8.
2
Recreational use of phosphodiesterase type 5 inhibitors by healthy young men.健康年轻男性 recreational 使用 5 型磷酸二酯酶抑制剂。
J Sex Med. 2010 Nov;7(11):3736-42. doi: 10.1111/j.1743-6109.2010.01965.x. Epub 2010 Aug 16.
3
Use of phosphodiesterase-5 inhibitors by college students.
EDEUS:一项关于5型磷酸二酯酶抑制剂使用者的真实生活研究——聚焦第二代阿伐那非的欧洲男性的患病率、认知及就医行为
Sex Med. 2018 Mar;6(1):15-23. doi: 10.1016/j.esxm.2017.10.003. Epub 2017 Dec 21.
4
Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men.性增强药物使用者的人口统计学和性特征:对性活跃男性基于网络的横断面样本的研究。
Arab J Urol. 2017 Nov 6;15(4):366-371. doi: 10.1016/j.aju.2017.09.003. eCollection 2017 Dec.
大学生使用磷酸二酯酶-5抑制剂的情况。
Rev Saude Publica. 2008 Oct;42(5):965-7. Epub 2008 Aug 21.
4
Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students.年轻健康男性对5型磷酸二酯酶抑制剂的娱乐性使用:在医学生中认识到这一问题。
J Sex Med. 2008 Oct;5(10):2414-8. doi: 10.1111/j.1743-6109.2008.00792.x. Epub 2008 Mar 4.
5
British Society for Sexual Medicine guidelines on the management of erectile dysfunction.英国性医学学会勃起功能障碍管理指南。
J Sex Med. 2008 Aug;5(8):1841-65. doi: 10.1111/j.1743-6109.2008.00773.x. Epub 2008 Feb 21.
6
Recreational use of erectile dysfunction medication may decrease confidence in ability to gain and hold erections in young males.年轻男性娱乐性使用勃起功能障碍药物可能会降低其对获得和维持勃起能力的信心。
Int J Impot Res. 2007 Nov-Dec;19(6):591-6. doi: 10.1038/sj.ijir.3901584. Epub 2007 Jul 26.
7
Journey into the realm of requests for help presented to sexual medicine specialists: introducing male sexual distress.探索向性医学专家求助的领域:介绍男性性困扰。
J Sex Med. 2007 May;4(3):762-770. doi: 10.1111/j.1743-6109.2007.00460.x. Epub 2007 Apr 13.
8
Erectile dysfunction and viagra use: what's up with college-age males?勃起功能障碍与伟哥的使用:大学生年龄段男性的情况如何?
J Adolesc Health. 2006 Sep;39(3):452-4. doi: 10.1016/j.jadohealth.2005.12.021. Epub 2006 Jul 10.
9
Clinical evaluation and management strategy for sexual dysfunction in men and women.男性和女性性功能障碍的临床评估与管理策略
J Sex Med. 2004 Jul;1(1):49-57. doi: 10.1111/j.1743-6109.2004.10108.x.
10
Recreational use and misuse of phosphodiesterase 5 inhibitors.磷酸二酯酶5抑制剂的娱乐性使用和滥用。
J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):63-72; quiz 73-5.